相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression
Meiyan Qi et al.
NATURE COMMUNICATIONS (2022)
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
J. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
DNMT1: A key drug target in triple-negative breast cancer
Kah Keng Wong
SEMINARS IN CANCER BIOLOGY (2021)
Metaplastic breast cancer: Prognostic and therapeutic considerations
Giovanni Corso et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai et al.
MOLECULAR CANCER (2021)
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez et al.
NATURE COMMUNICATIONS (2021)
Signaling pathways governing breast cancer stem cells behavior
Kai Song et al.
STEM CELL RESEARCH & THERAPY (2021)
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients
Nuala Helsby et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
R. K. Murthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells
Riley A. Hampsch et al.
CLINICAL CANCER RESEARCH (2020)
Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
Beatriz Ballester et al.
Oncotarget (2020)
A three layered histone epigenetics in breast cancer metastasis
Debparna Nandy et al.
CELL AND BIOSCIENCE (2020)
Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer
Nora Feldker et al.
EMBO JOURNAL (2020)
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Rasmus Siersbaek et al.
CANCER CELL (2020)
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Shihori Tanabe et al.
FRONTIERS IN PHARMACOLOGY (2020)
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
Zhongwei Li et al.
CELL DEATH AND DIFFERENTIATION (2020)
DNA Methylation and Breast Cancer Risk: An Epigenome-Wide Study of Normal Breast Tissue and Blood
Kaoutar Ennour-Idrissi et al.
CANCERS (2020)
Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis
Jialang Zhuang et al.
FRONTIERS IN GENETICS (2020)
Epigenetic alterations in cancer
Suganya Ilango et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2020)
Epigenetics in Metastatic Breast Cancer Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics
Yuan Seng Wu et al.
CURRENT CANCER DRUG TARGETS (2019)
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Kuppusamy Balamurugan et al.
ONCOGENE (2019)
The role of histone deacetylase inhibitors in metastatic breast cancer
Bruna Zucchetti et al.
BREAST (2019)
Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Ana C. Garrido-Castro et al.
CANCER DISCOVERY (2019)
Context-dependent EMT programs in cancer metastasis
Nicole M. Aiello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Epidrugs: targeting epigenetic marks in cancer treatment
Cristiana Libardi Miranda Furtado et al.
EPIGENETICS (2019)
Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy
Yu Zhang et al.
ONCOLOGY LETTERS (2019)
IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling
Wei Hu et al.
SCIENTIFIC REPORTS (2019)
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
Liping Ye et al.
EMBO MOLECULAR MEDICINE (2019)
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias et al.
EUROPEAN JOURNAL OF CANCER (2019)
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer A Phase 1 Study
Leisha A. Emens et al.
JAMA ONCOLOGY (2019)
BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling
Sanghyuk Choi et al.
SCIENTIFIC REPORTS (2019)
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
Tala M. Abu Samaan et al.
BIOMOLECULES (2019)
Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities
Kanisha Shah et al.
CURRENT DRUG METABOLISM (2019)
Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies
Shu-Ching M. Wang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2019)
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
Jiani Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Controversies around epithelial-mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams et al.
NATURE REVIEWS CANCER (2019)
Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
Jonathan M. Yingling et al.
Oncotarget (2018)
Macrophage targeting: opening new possibilities for cancer immunotherapy
Luca Cassetta et al.
IMMUNOLOGY (2018)
E-cadherin in contact inhibition and cancer
Alisha M. Mendonsa et al.
ONCOGENE (2018)
Adipocyte biology in breast cancer: From silent bystander to active facilitator
Junjeong Choi et al.
PROGRESS IN LIPID RESEARCH (2018)
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis
Noemi Eiro et al.
CELLULAR ONCOLOGY (2018)
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B. Holmgaard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
Kideok Jin et al.
BREAST CANCER RESEARCH (2018)
A history of exploring cancer in context
Shelly Maman et al.
NATURE REVIEWS CANCER (2018)
Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
Jennifer L. Caswell-Jin et al.
JNCI CANCER SPECTRUM (2018)
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
Jill J. J. Geenen et al.
CLINICAL PHARMACOKINETICS (2018)
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
Rico D. Bense et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Marzia A. Locatelli et al.
ONCOTARGET (2017)
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
Rico D. Bense et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
TETI inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2
Hongying Duan et al.
GYNECOLOGIC ONCOLOGY (2017)
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
Christiana Polydorou et al.
ONCOTARGET (2017)
Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype
W. A. da Silveira et al.
SCIENTIFIC REPORTS (2017)
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer
Ayman Shafei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death
Xiaoya Wang et al.
CANCER LETTERS (2017)
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy
Richard E. Kast et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression
Manuel Picon-Ruiz et al.
CANCER RESEARCH (2016)
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
Marie-Caroline Dieu-Nosjean et al.
IMMUNOLOGICAL REVIEWS (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Biomarkers for EMT and MET in breast cancer: An update
Fei Liu et al.
ONCOLOGY LETTERS (2016)
Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/beta-catenin pathway
Xingcong Ma et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Saber Imani et al.
SCIENTIFIC REPORTS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Dysfunction of the Reciprocal Feedback Loop between GATA3-and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis
Wenzhe Si et al.
CANCER CELL (2015)
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours
S. A. Piha-Paul et al.
EUROPEAN JOURNAL OF CANCER (2015)
HES1-mediated inhibition of Notchl signaling by a Gemini vitamin D analog leads to decreased CD44+/CD24-/low tumor-initiating subpopulation in basal-like breast cancer
Jae Young So et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting Breast Cancer Metastasis
Xin Jin et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state
Masayuki Shimoda et al.
NATURE CELL BIOLOGY (2014)
Slug/β-Catenin Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells
Gianluca Storci et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Breast Cancer Metastasis Issues for the Personalization of Its Prevention and Treatment
Natascia Marino et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer
Erica L. Mayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells
Qinglin Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
The Many Faces of C/EBPδ and their Relevance for Inflammation and Cancer
Kuppusamy Balamurugan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins
Sameer Mirza et al.
JOURNAL OF BREAST CANCER (2013)
CANCER The to and fro of tumour spread
Bryce J. W. van Denderen et al.
NATURE (2013)
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer
C. Dong et al.
ONCOGENE (2013)
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
F. Andre et al.
ANNALS OF ONCOLOGY (2012)
Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Chiara Foroni et al.
CANCER TREATMENT REVIEWS (2012)
Breast-cancer stem cells-beyond semantics
Sunil Badve et al.
LANCET ONCOLOGY (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Jingqi Chen et al.
CANCER CELL (2011)
Plasminogen Activator uPA Is a Direct Transcriptional Target of the JAG1-Notch Receptor Signaling Pathway in Breast Cancer
Mamiko Shimizu et al.
CANCER RESEARCH (2011)
Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion
Beatrice Dirat et al.
CANCER RESEARCH (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Dimitrios Iliopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E. Place et al.
BREAST CANCER RESEARCH (2011)
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
M. Walter et al.
ONCOGENE (2009)
Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
Farhad Vesuna et al.
NEOPLASIA (2009)
HER2+breast cancer
David G. Hicks et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches
Paola Rizzo et al.
CANCER RESEARCH (2008)
Regulation of multiple angiogenic pathways by D114 and Notch in human umbilical vein endothelial cells
Laura S. Harrington et al.
MICROVASCULAR RESEARCH (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
A transcriptional program mediating entry into cellular quiescence
Helen Liu et al.
PLOS GENETICS (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies
F Lyko et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
DM Brown et al.
CANCER CELL (2004)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
S Aharinejad et al.
CANCER RESEARCH (2004)
Notch in mammary gland development and breast cancer
K Politi et al.
SEMINARS IN CANCER BIOLOGY (2004)
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer:: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability
D Sarrió et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
